Skip to main content
TipRanks
Go Ultimate75% OFF
Ansa Biotechnologies Inc logo

Ansa Biotechnologies Inc: Valuation, Funding & Investors

Ansa Biotechnologies Inc, headquartered in Emeryville, California, is revolutionizing DNA synthesis through its proprietary enzymatic platform. The company offers a sustainable approach that enables the synthesis of longer and more complex DNA sequences without harsh chemicals, thus preserving DNA integrity. Ansa's innovative technology supports advancements in gene and cell therapy, vaccines, agrigenomics, and synthetic biology, empowering scientists to accelerate discoveries and design at scale. With a commitment to quality and customer satisfaction, Ansa provides sequence-perfect clonal DNA and sequence-verified linear double-stranded DNA fragments, facilitating the industry's transition from genome reading to writing.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$54M
Total Funding Rounds
1
Latest Funding Amount
$54M
Latest Funding Round
Series B

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Oct 08, 2025Series B$54.40M―

Investors

Similar Companies

A snapshot of private companies similar to Ansa Biotechnologies Inc, helping you discover and navigate related company profiles.

Related News and Analysis